Ultragenyx (RARE) — Capital Reinvestment Ratio
Latest as of June 2020:
0.05x
Ultragenyx (RARE) has a Capital Reinvestment Ratio of 0.05x as of June 2020, meaning it reinvests 0% of its operating cash flow ($87.35 Million) in capital expenditures ($4.08 Million). See RARE net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$87.35 Million
USD
Capital Expenditures
$4.08 Million
USD
Data as of
Jun 2020
Most recent filing
Annual Capital Reinvestment Ratio for Ultragenyx (None–None)
Year-by-year Capital Reinvestment Ratio for Ultragenyx from None to None. For live market cap and broader valuation context, see Ultragenyx (RARE) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow